Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system

American Journal of Transplantation

Volumn 10, Issue 7, 2010, Pages 1643-1648

  Washburn, K ^a   Edwards, E ^b   Harper, A ^b   Freeman, R ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Allocation; hepatocellular carcinoma; liver transplantation; MELD score

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER PATIENT; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR VOLUME; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; HEALTH CARE POLICY; MELD SCORE; OVERALL SURVIVAL; PATIENT CARE; PREDICTOR VARIABLE; PROBABILITY; RADIOFREQUENCY ABLATION; RATING SCALE; REPRODUCIBILITY; RISK ASSESSMENT; TREATMENT REFUSAL; CANCER STAGING; HEALTH CARE ORGANIZATION; LIVER TUMOR; METHODOLOGY; PATHOLOGY; PATIENT; PREDICTIVE VALUE; RESOURCE ALLOCATION; STANDARD; STATISTICS;

CARCINOMA, HEPATOCELLULAR; HEALTH CARE RATIONING; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; PATIENT DROPOUTS; PREDICTIVE VALUE OF TESTS; RESOURCE ALLOCATION; RISK ASSESSMENT; WAITING LISTS;

EID: 79958055243     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03127.x     Document Type: Article

References (20)

1. Freeman RB Jr., Wiesner RH, Harper A et al. The new liver allocation system: Moving towards evidence-based transplantation policy. Liver Transpl 2002 8 : 851 858.
2. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 334 : 693 699.
3. Yao FY, Bass NM, Nikolai B et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy. Liver Transpl 2003 9 : 684 692.
4. Freeman RB Jr., Steffick DE, Guidinger MK, Farmer DG, Berg CL, Merion RM. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 2008 8 (4 Pt 2 958 976.
5. Kalbfleisch JD and Prentice RL. The statistical analysis of failure time data.
6. Aalen O. Nonparametric estimation of partial transition probabilities in multiple decrement models. Ann Stat 1978 6 : 534 545.
7. Fine JP and Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA 1999 94 : 496 509.
8. Kim WR, Therneau TM, Benson JT et al. Deaths on the liver transplant waiting list: An analysis of competing risks. Hepatology 2006 43 : 345 351.
9. Freeman RB, Edwards EB, Harper AM. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 2006 6 : 1416 1421.
10. Smits JM, van Houwelingen HC, De Meester J, Persijn GG, Claas FH. Analysis of the renal transplant waiting list: Application of a parametric competing risk method. Transplantation 1998 66 : 1146 1153.
11. McGiffin DC, Naftel DC, Kirklin JK et al. Predicting outcome after listing for heart transplantation in children: Comparison of Kaplan-Meier and parametric competing risk analysis. Pediatric Heart Transplant Study Group J Heart Lung Transplant 1997 16 : 713 722.
12. Wiesner RH, McDiarmid SV, Kamath PS et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001 7 : 567 580.
13. Pelletier SJ, Fu S, Thyagarajan V et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 2009 15 : 859 868.
14. Saab S, Ly D, Nieto J et al. Hepatocellular carcinoma screening in patients waiting for liver transplantation: A decision analytic model. Liver Transpl 2003 9 : 672 681.
15. Ravaioli M, Ercolani G, Cescon M et al. Liver transplantation for hepatocellular carcinoma: Further considerations on selection criteria. Liver Transpl 2004 10 : 1195 1202. (Pubitemid 39248420)
16. Yang SH, Suh KS, Lee HW et al. A revised scoring system utilizing serum alphafetoprotein levels to expand patients for living donor transplantation in hepatocellular carcinoma. Surgery 2007 141 : 598 609.
17. Vitale A, Saracino E, D'Amico FE et al. Prospective validation of a new priority allocation model for liver transplant patients: An interim analysis. Transplant Proc 2009 41 : 1092 1095.
18. Maddala YK, Stadheim L, Andrews JC et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization. Liver Transpl 2004 10 : 449 455.
19. Millonig G, Graziadei IW, Freund MC et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007 13 : 272 279.
20. Mazzaferro V, Battiston C, Perrone S et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: A prospective study. Ann Surg 2004 240 : 900 909.